Close Menu

NEW YORK – Axovant Gene Therapies, a drugmaker focused on neurological diseases, has partnered with genetic testing firm Invitae to launch a free genetic testing and counseling program for children, called Detect Lysosomal Storage Diseases.

The program aims to reduce misdiagnosis and underdiagnosis of lysosomal storage disorders (LSDs) GM1 and GM2 gangliosidosis, otherwise known as Tay-Sachs and Sandhoff disease. Within the program, Invitae will provide free genetic testing on a 53-gene panel and counseling to patients suspected of having an LSD.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.